Top Markets
#1 ADO Protocol ADO Protocol +329.47%
#2 GoPlus Security GoPlus Security +54.27%
#3 Nockchain Nockchain +46.24%
#4 Tutorial Tutorial +35.05%
#5 Starpower Starpower +34.11%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.96%
#7 The Black Bull The Black Bull +31.29%
#8 GAIB AID GAIB AID +24.67%
#9 Casper Network Casper Network +21.33%
#10 Verus Coin Verus Coin +20.40%
Coin of the day
ADO Protocol ADO Protocol
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
China Regenerative Medicine International Limited China Regenerative Medicine International Limited

China Regenerative Medicine International Limited

8158
Hisse Senetlerindeki Sıralama #32811
China Regenerative Medicine International Limited operates as an investment... China Regenerative Medicine International Limited operates as an investment holding entity, focusing on the development and distribution of a diverse portfolio of healthcare products and associated services. The company provides extensive health management solutions, covering health condition assessments, detoxification programs, fostering internal bodily balance, nourishing vital organs, and enhancing the immune system. Additionally, its beauty offerings encompass non-surgical medical aesthetics, essential dermatological care, anti-aging skin remedies, hair revitalization, skin firming treatments, localized body contouring, and intimate restoration services. Established in 1995, the organization was previously known as China Bio-Med Regeneration Technology Limited until its rebranding to China Regenerative Medicine International Limited in March 2015. Its headquarters are situated in Tsim Sha Tsui, Hong Kong.
Hisse Fiyatı
$0.02967889
Son senkronizasyon: 2026-08-12
Piyasa Değeri
$9.03M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-72.68%
Ülke
HK
Ticaret China Regenerative Medicine International Limited (8158)

Kategori

Healthcare
China Regenerative Medicine International Limited (8158) için kazanç
2026 itibarıyla kazanç TTM: 0
China Regenerative Medicine International Limited şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
China Regenerative Medicine International Limited için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE